BNP Paribas Financial Markets’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-49
| Closed | -$39 | – | 4372 |
|
|
2020
Q2 | $39 | Sell |
49
-28
| -36% | -$24 | ﹤0.01% | 4237 |
|
|
2020
Q1 | $53 | Hold |
77
| – | – | ﹤0.01% | 4240 |
|
|
2019
Q4 | $122 | Sell |
77
-1,133
| -94% | -$3.17K | ﹤0.01% | 4325 |
|
|
2019
Q3 | $4.8K | Hold |
1,210
| – | – | ﹤0.01% | 4277 |
|
|
2019
Q2 | $8.76K | Buy |
+1,210
| New | +$8.25K | ﹤0.01% | 4127 |
|
|
2019
Q1 | – | Sell |
-184
| Closed | -$1.32K | – | 4483 |
|
|
2018
Q4 | $1.32K | Sell |
184
-118
| -39% | -$1.31K | ﹤0.01% | 3884 |
|
|
2018
Q3 | $5.77K | Sell |
302
-90
| -23% | -$3.21K | ﹤0.01% | 3988 |
|
|
2018
Q2 | $22.2K | Sell |
392
-1,356
| -78% | -$68.8K | ﹤0.01% | 3457 |
|
|
2018
Q1 | $73.9K | Buy |
1,748
+17
| +1% | +$730 | ﹤0.01% | 3344 |
|
|
2017
Q4 | $92.6K | Buy |
1,731
+488
| +39% | +$25.8K | ﹤0.01% | 3343 |
|
|
2017
Q3 | $55.4K | Sell |
1,243
-61
| -5% | -$2.78K | ﹤0.01% | 3095 |
|
|
2017
Q2 | $63.4K | Buy |
1,304
+808
| +163% | +$47.6K | ﹤0.01% | 3060 |
|
|
2017
Q1 | $35.9K | Sell |
496
-804
| -62% | -$53.2K | ﹤0.01% | 2854 |
|
|
2016
Q4 | $74.4K | Buy |
1,300
+116
| +10% | +$10.6K | ﹤0.01% | 2660 |
|
|
2016
Q3 | $152K | Buy |
1,184
+405
| +52% | +$51.8K | ﹤0.01% | 1887 |
|
|
2016
Q2 | $97.1K | Buy |
779
+268
| +52% | +$30.8K | ﹤0.01% | 2126 |
|
|
2016
Q1 | $42.7K | Sell |
511
-1,301
| -72% | -$107K | ﹤0.01% | 2046 |
|
|
2015
Q4 | $179K | Buy |
1,812
+338
| +23% | +$36.2K | ﹤0.01% | 2014 |
|
|
2015
Q3 | $181K | Buy |
1,474
+913
| +163% | +$124K | ﹤0.01% | 2028 |
|
|
2015
Q2 | $86K | Buy |
561
+410
| +272% | +$67.7K | ﹤0.01% | 2158 |
|
|
2015
Q1 | $25.8K | Buy |
+151
| New | +$22.9K | ﹤0.01% | 2247 |
|
|
2014
Q4 | – | Sell |
-747
| Closed | -$79.2K | – | 3647 |
|
|
2014
Q3 | $79.2K | Buy |
747
+386
| +107% | +$53.8K | ﹤0.01% | 2331 |
|
|
2014
Q2 | $55K | Buy |
361
+1
| +0.3% | +$133 | ﹤0.01% | 2121 |
|
|
2014
Q1 | $45.7K | Buy |
360
+12
| +3% | +$1.87K | ﹤0.01% | 2140 |
|
|
2013
Q4 | $60.7K | Sell |
348
-1,381
| -80% | -$237K | ﹤0.01% | 1837 |
|
|
2013
Q3 | $279K | Sell |
1,729
-497
| -22% | -$78.3K | ﹤0.01% | 1981 |
|
|
2013
Q2 | $296K | Buy |
+2,226
| New | +$314K | ﹤0.01% | 2012 |
|
Other funds holding ELGX
BNP Paribas Financial Markets's ELGX Position: Q3 2020 in Review
BNP Paribas Financial Markets sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 49 shares — an estimated $39 sold.
BNP Paribas Financial Markets first reported a position in ELGX in Q2 2013 and held it in 27 quarters. The position peaked at $296K in Q2 2013. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.
- BNP Paribas Financial Markets reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
- BNP Paribas Financial Markets sold 49 Endologix Inc shares in Q3 2020, an estimated $39.
- BNP Paribas Financial Markets first reported a position in Endologix Inc in Q2 2013 and held it in 27 quarters.
- BNP Paribas Financial Markets's Endologix Inc position peaked at $296K in Q2 2013.
- 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2020, filed 30 Oct 2020.